Aemetis Reduces Senior Bridge Loan by $6 million with Phase I EB-5 Funding

Aemetis Reduces Senior Bridge Loan by $6 million with Phase I EB-5 Funding

EB-5 Visa, EB5 Visa, EB-5 Investment

86% of $36 million EB-5 Phase I Funding Received by the Company; EB-5 Financing is Repaying 14% High Cost Bridge Loan with 3% Low Cost, Long Term Funding

Aemetis, Inc. (NASDAQ: AMTX), an advanced fuels and renewable chemicals company, announced that $6 million has been received from EB5 funding, resulting in 86% of the $36 million EB-5 Phase I funding having been received by the company. The $6 million repays the existing 14% interest rate bridge loan with 3% interest rate, long term EB-5 funding.

Under the EB-5 Phase I funding, Aemetis offered subordinated notes in the amount of $500,000 per note to refinance the high interest rate bridge loan for the existing Keyes ethanol plant, and raised $36 million from 72 foreign investors. To date, $31 million of this amount has been released from the EB-5escrow account to the company and used to reduce a higher cost bridge loan held by our senior lender. After applying the $6 million, the senior bridge loan reduced to $62.5 million.

With an EB-5 project track record established, Aemetis recently commenced a $50 million Phase II funding in September 2016. Aemetis' financing plan is to repay its high cost senior bridge loan with low cost EB-5 funding and funds from operations. This repayment of the senior bridge loan is expected to result in significant interest rate savings.

About Aemetis, Inc.:

Headquartered in Cupertino, California, Aemetis is an advanced fuels and renewable chemicals company founded in 2006. Aemetis owns and operates a 60 million gallons per year ethanol and 420,000-ton animal feed plant in California. Aemetis also owns and operates a 50-million-gallon capacity renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds granted patents on technology for the production of renewable fuels and biochemicals.



  • California

Securities Disclaimer

This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.